Trillium Therapeutics Inc (TRIL) Return on Investment ROI from the third quarter of 2021 to third quarter of 2020 and for the year 2021, average high and low, overall ranking from Sep 30 2021 to Sep 30 2020 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Trillium Therapeutics Inc   (NASDAQ: TRIL)


Trillium Therapeutics Inc's ROI from its third quarter of 2021 to the third quarter of 2020 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Trillium Therapeutics Inc's ROI in the third quarter of 2021?
Trillium Therapeutics Inc recorded a cumulative net loss of $-56 million during 12 months ending in the third quarter of 2021, resulting in a negative return on investment (ROI) of -21.17%.

Within the Healthcare sector 585 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2021 from 0 to 4200.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter
Y / Y Investment Change TTM 2178.93 % 1194.85 % 585.29 % 200.8 % -62.83 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 244 260 273 279 11
Return On Investment (TTM) -21.17 % -23.84 % -37.47 % -75.63 % -89.75 %
TRIL's Overall Ranking # 4200 # 0 # 0 # 0 #
Seq. Investment Change TTM 28.26 % 43.11 % 83.35 % 577.12 % -27.12 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -56 -49 -54 -59 -10

TRIL Company Profile >> Back to TRIL Roi Comparisons >> See Annual TRIL Return On Investment



Return On Investment TRIL's Ranking
Within: No.
Industry # 247
Sector # 586
Overall # 4200

Return On Investment Statistics
High Average Low
359.16 %
51.98 %
-124.21 %
(Dec 31 2019)   (Dec 31 2020)







Financial Statements
Trillium Therapeutics Inc's III. Quarter Investments $ 244 Millions TRIL's Balance sheet
Trillium Therapeutics Inc's III. Quarter Income $ -19 Millions Quarterly TRIL's Income Statement
TRIL's Income by Division See TRIL's Income by Division


TRIL Annual Return On Investment (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017
Total Investments in Millions 279 11 28 78 0
Y / Y Investment Growth 2507.6 % -61.69 % -64.23 % - -
Net Income in Millions -59 -38 -33 -35 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -21.24 % -355.41 % -117.52 % -44.46 % -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
TRIL's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for TRIL's Competitors
Subscribers only: Roi for Trillium Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for TRIL's Customers

Other Ratios
TRIL's Roa TRIL's Inventory Turnover Ratio TRIL's Growth Rates TRIL's Dividend Statistics
TRIL's Profitability Ratios TRIL's Asset Turnover Ratio TRIL's Dividend Growth
TRIL's Roe TRIL's Valuation Ratios TRIL's Financial Strength Ratios TRIL's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2021, within Healthcare Sector ROI

Date modified: 2026-09-30T13:42:12+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.